Imunon, Inc.
CLSN
Classement en actions
#34963
Imunon, Inc. is a biotechnology firm in the clinical development stage,... Imunon, Inc. is a biotechnology firm in the clinical development stage, dedicated to innovating and commercializing DNA-centric immunotherapies, vaccines, and targeted chemotherapy solutions. Its primary pipeline assets include GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a unique formulation of doxorubicin encapsulated in heat-activated liposomes, currently being assessed for a variety of cancer indications. Furthermore, the company is advancing two early-phase platform technologies aimed at developing nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA treatments. Established in 1982, Imunon, Inc. maintains its operational base in Lawrenceville, New Jersey.
Prix de l'action
$1.96
Dernière synchronisation: 2022-09-20
Capitalisation boursière
$4.46M
Changement (1 jour)
0.00%
Changement (1 an)
122.70%
Pays
US
Échange Imunon, Inc. (CLSN)
Catégorie
Healthcare
Capitalisation boursière de Imunon, Inc.(CLSN)
Capitalisation boursière: $4.46M
En October 2026, Imunon, Inc. a une capitalisation boursière de $4.46M. Cela fait de Imunon, Inc. la 34963rd entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Imunon, Inc. du 2018 au 2026
CLSN par rapport au top 5 des plus populaires stocks
| Prix pour CLSN | L’actif B | La capitalisation boursière de B | Résultats | |
|---|---|---|---|---|
$2,083,714
$2.22M
|
$5.252T | +236,758,709.66% | ||
|
$1,984,108
$2.22M
|
$5.001T | +225,441,100.58% | ||
|
$1,656,765
$2.22M
|
$4.176T | +188,247,251.40% | ||
|
$1,574,211
$2.22M
|
$3.968T | +178,867,212.23% | ||
|
$1,125,536
$2.22M
|
$2.837T | +127,887,212.85% |
